首页> 外文期刊>AACN advanced critical care >Drug Update Pharmacologic Management of Status Epilepticus
【24h】

Drug Update Pharmacologic Management of Status Epilepticus

机译:药物更新状态癫痫患者药理学管理

获取原文
获取原文并翻译 | 示例
       

摘要

Status epilepticus (SE) is a neurological emergency defined as 5 minutes or more of continuous seizure activity or recurrent seizures without a return to baseline between seizures. Previous definitions required seizure activity to last for at least 30 minutes before being considered SE. However, earlier intervention is required to reduce morbidity and mortality from permanent neuronal damage. Treatment of SE centers on rapid control of seizures with benzodiaz-epines in the emergent-control phase, followed by urgent-control therapy with intravenous antiepileptic drugs (AEDs) to prevent further seizures. Patients whose seizures do not respond to adequate urgent- and emergent-control therapy are considered to have refractory SE (RSE). The longer patients' seizures last, the more difficult it is to terminate the seizures, often requiring multiple AEDs, intubation, and continuous-infusion anesthetic medications to achieve seizure termination.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号